TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06884865: A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee

Sponsor: Pacira Pharmaceuticals, Inc · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 135 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,656,500

Rescue Site Savings

+$1,759,500

Unlock Full NCT06884865 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06884865 Rescue Dossier →